Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Prestige Consumer Healthcare (PBH) Enterprise Value (2016 - 2025)

Historic Enterprise Value for Prestige Consumer Healthcare (PBH) over the last 17 years, with Q4 2025 value amounting to -$62.4 million.

  • Prestige Consumer Healthcare's Enterprise Value fell 2260.29% to -$62.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$62.4 million, marking a year-over-year decrease of 2260.29%. This contributed to the annual value of -$97.9 million for FY2025, which is 11064.37% down from last year.
  • Latest data reveals that Prestige Consumer Healthcare reported Enterprise Value of -$62.4 million as of Q4 2025, which was down 2260.29% from -$119.1 million recorded in Q3 2025.
  • In the past 5 years, Prestige Consumer Healthcare's Enterprise Value ranged from a high of -$21.0 million in Q4 2021 and a low of -$163.6 million during Q2 2021
  • Its 5-year average for Enterprise Value is -$64.5 million, with a median of -$53.1 million in 2023.
  • Within the past 5 years, the most significant YoY rise in Prestige Consumer Healthcare's Enterprise Value was 7807.84% (2022), while the steepest drop was 31087.64% (2022).
  • Over the past 5 years, Prestige Consumer Healthcare's Enterprise Value (Quarter) stood at -$21.0 million in 2021, then crashed by 310.88% to -$86.4 million in 2022, then increased by 26.34% to -$63.6 million in 2023, then rose by 20.03% to -$50.9 million in 2024, then dropped by 22.6% to -$62.4 million in 2025.
  • Its Enterprise Value stands at -$62.4 million for Q4 2025, versus -$119.1 million for Q3 2025 and -$139.5 million for Q2 2025.